Quick Answer
Cingulate Inc. reported Net Income of -$22.45 million for fiscal year 2025.
Cingulate Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$22.45M -35.6% |
-$16.56M +29.6% |
-$23.53M -33.1% |
-$17.68M +14.6% |
-$20.71M -188.3% |
-$7.18M |
| Diluted EPS | -$4.44 +59.1% |
-$10.86 +96.5% |
-$311.99 -963.0% |
-$29.35 | — | — |
| Total Assets | $15.07M +1.4% |
$14.86M +325.7% |
$3.49M -69.4% |
$11.41M -50.2% |
$22.89M +295.4% |
$5.79M |
| Cash and Equivalents | $10.95M -10.3% |
$12.21M +23196.9% |
$52.4K -99.0% |
$5.36M -67.5% |
$16.49M +1277.1% |
$1.20M |
| Stockholders Equity | $2.51M -66.3% |
$7.46M +208.5% |
-$6.87M -277.0% |
$3.88M -81.4% |
$20.84M +1512.7% |
$1.29M +109.9% |
| R&D Expense | $9.77M +3.5% |
$9.45M -39.0% |
$15.49M +72.2% |
$9.00M +7.0% |
$8.41M +65.1% |
$5.09M |
| Operating Income | -$19.94M -27.4% |
-$15.64M +31.3% |
-$22.76M -30.0% |
-$17.50M +15.4% |
-$20.68M -191.9% |
-$7.08M |
| Shares Outstanding | 7.25M +113.1% |
3.40M +3397.0% |
97,293 -83.9% |
602,640 -94.7% |
11.31M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$7.34M | -77.9% | -47.3% |
| Diluted EPS | September 30, 2025 | -$1.35 | +42.3% | -23.9% |
| Total Assets | September 30, 2025 | $10.52M | -22.5% | -21.9% |
| Cash and Equivalents | September 30, 2025 | $6.12M | -39.1% | -31.3% |
| Stockholders Equity | September 30, 2025 | $3.47M | -71.1% | -37.0% |
| R&D Expense | September 30, 2025 | $2.85M | +99.4% | +5.5% |
| Operating Income | September 30, 2025 | -$6.00M | -82.7% | -28.9% |
| Shares Outstanding | September 30, 2025 | 5.98M | +96.4% | +22.3% |
- Cingulate Inc. reported Net Income of -$22.45 million for fiscal year 2025.
- Cingulate Inc. showed a decrease of -35.6% in Net Income compared to the prior fiscal year.
- Cingulate Inc. reported Diluted EPS of $4.44 per share (loss) for fiscal year 2025.
- Cingulate Inc. showed an increase of +59.1% in Diluted EPS compared to the prior fiscal year.
- Cingulate Inc. reported Total Assets of $15.07 million for fiscal year 2025.
- Cingulate Inc. showed an increase of +1.4% in Total Assets compared to the prior fiscal year.
- Cingulate Inc. reported Cash and Equivalents of $10.95 million for fiscal year 2025.
- Cingulate Inc. showed a decrease of -10.3% in Cash and Equivalents compared to the prior fiscal year.
- Cingulate Inc. reported Stockholders Equity of $2.51 million for fiscal year 2025.
- Cingulate Inc. showed a decrease of -66.3% in Stockholders Equity compared to the prior fiscal year.
- Cingulate Inc. reported R&D Expense of $9.77 million for fiscal year 2025.
- Cingulate Inc. showed an increase of +3.5% in R&D Expense compared to the prior fiscal year.
- Cingulate Inc. reported Operating Income of -$19.94 million for fiscal year 2025.
- Cingulate Inc. showed a decrease of -27.4% in Operating Income compared to the prior fiscal year.
- Cingulate Inc. reported Shares Outstanding of 7.25 million shares for fiscal year 2025.
- Cingulate Inc. showed an increase of +113.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: